Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.3) was added to the study record history, replacing the previous revision (v3.5.2). This reflects a platform/version update rather than any change to the trial content.
    Difference
    0.1%
    Check dated 2026-04-30T17:03:07.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.1%
    Check dated 2026-04-16T11:16:17.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Added a revision entry for v3.5.0 and removed the v3.4.3 entry from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T21:09:30.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 in the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:07.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1 from the history.
    Difference
    0.6%
    Check dated 2026-02-11T10:20:10.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:12:53.000Z thumbnail image

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.